CNTA
Centessa Pharmaceuticals plc American Depositary Shares
PHARMACEUTICAL PREPARATIONS
Best Pharmaceutical Stocks 2026 →
Centessa Pharmaceuticals (CNTA) Stock: Buy, Sell, or Hold?
$40.50
+0.32 (+0.80%)
â˛
5d:
+1.86%
30d:
+1.73%
90d:
+56.13%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (64%)
Quality Score
48/100
Position
FAIR
Forward P/E & Valuation
-22.6x
Next 12M consensus est.
Wall Street Target
$44.17
+9.1% upside
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$39.58 / $40.56
Trend: Strong Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
âšī¸ NEUTRAL: CNTA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
Get Alerted When CNTA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: CNTA is currently trading at $40.50, which is considered fair based on recent price action.
Technical Outlook: Technically, CNTA is in a strong uptrend. The price is currently testing key support at $39.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CNTA is in a strong uptrend. The price is currently testing key support at $39.58. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Company Quality Score
48/100
(HOLD)
Volume Confirmation
UNKNOWN
Confidence Score
64.2%
Trading Range & Key Levels
Support Level
$39.58
Resistance Level
$40.56
Current Trend
Strong Uptrend
Technical data as of
Jun 23, 2026
Quantitative Signal Breakdown
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (40/100)
- NEUTRAL: Near Wall St target ($44.17)
- WARNING: Composite score 48/100 in the bottom quintile â this cohort historically lags the market
Fundamental Context
Forward P/E (Next Year Est.)
-22.64
Wall Street Target
$44.17
(+9.1%)
Share CNTA Analysis
Share this live CNTA analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (CNTA)
Bullish
1 Retail Mentions
Reddit / WSB Comments
1
Bullish
Last Tracked
Jun 5, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on CNTA are bullish (sentiment score +0.71) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 11, 2026 8:34 AM ET
Data refreshes hourly during market hours. Next update: 9:34 AM
Data refreshes hourly during market hours. Next update: 9:34 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CNTA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 43 HOLD |
|
DNLI
Denali Therapeutics Inc |
STRONG BUY
20 analysts |
$36 | 37 SELL |
|
SRRK
Scholar Rock Holding Corp |
STRONG BUY
18 analysts |
$70 | 39 SELL |
|
ARWR
Arrowhead PharmaceuticalâĻ |
STRONG BUY
15 analysts |
$108 | 47 HOLD |
|
MIRM
Mirum Pharmaceuticals Inc |
STRONG BUY
14 analysts |
$155 | 45 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive CNTA Research Pages
